In terms of metabolic indicators, insulin levels, homeostasis model assessment of insulin resistance (HOMA-IR), and hemoglobin A1c (HbA1c) were all significantly higher in the dyslipidemia group compared to the normal group (p < 0.05). This evidence concerns the gene INS and Insulin resistance.